For patients with ductal carcinoma in situ (DCIS), active monitoring (AM) is noninferior to guideline-concordant care (GCC) ...

A study based at Duke may change the standard of care for ductal carcinoma in situ (DCIS), known as stage zero breast cancer. A study based at Duke may change the standard of care for ductal carcinoma ...

The research, published in JAMA, suggests that active monitoring could be a viable alternative to surgery and radiation for low-risk patients with ductal carcinoma in situ (DCIS), known as stage zero ...

Research presented at the San Antonio Breast Cancer Symposium suggests women with early-stage breast cancer could safely ...

A new study, published in the New England Journal of Medicine, examines whether removing lymph nodes is always necessary in ...

A "watch-and-wait" strategy might be the best option for some women with early-stage, low-risk breast cancer. According to ...

A new clinical trial offers hope for women diagnosed with ductal carcinoma in situ (DCIS), indicating that surgery may not be essential. The trial, conducted on 957 women, revealed that those in ...

An analysis of phase 3 trials found tamoxifen significantly reduced 15-year ipsilateral breast recurrence in patients with ...

Some physicians who were not involved in the research cautioned that the study period was too short to draw firm conclusions, The Wall Street Journal reported. Researchers acknowledged longer-term ...

A "watch-and-wait" strategy might be the best option for some women with early-stage, low-risk breast cancer.

Centene told investors Tuesday that the company would get additional bonus payments after CMS updated its Medicare Advantage Star Ratings. More health industry news stories report on legal settlements ...

Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...